Data Points

Use the table below for descriptions of each of the data points entered into the Portal.

For information on how these data points correspond with HHS guidance, click here.

Section Data Point Data Upload Template Data Description Validation Rules
Therapeutics

39a. Current inventory on hand (in courses)

Column Header:

on_hand_supply_

Therapeutic_A_courses

 

Acceptable Values:

0 - 10,000

Enter the number of therapeutic A courses currently in inventory. This field has been designated as Casirivimab/Indevimab and is required as of 1/8/2021.

See Appendix D for additional information on therapeutic reporting.

 
Therapeutics

39b. Courses used in the last week

Column Header:

previous_week_

Therapeutic_A_courses_used

 

Acceptable Values:

0 - 5,000

Enter the number of therapeutic A courses used in the previous week (preferred week: Wednesday-Tuesday) in an inpatient, ED, overflow, or outpatient location such as an urgent care, infusion center, or outpatient clinic. This field has been designated as Casirivimab/Imdevimab and is required as of 1/8/2021.

 

See Appendix D for additional information on therapeutic reporting.

 
Therapeutics

40a. Current Inventory on hand (in courses)

Column Header:

on_hand_supply_

Therapeutic_C_courses

 

Acceptable Values:

0 - 10,000

Enter the number of therapeutic C courses currently in inventory. This field has been designated as Bamlanivimab/Etsevimab and is required as of 4/07/2021.

 

See Appendix D for additional information on therapeutic reporting.

 
Therapeutics

40b. Courses used in the last week

Column Header:

previous_week_

Therapeutic_C_courses_used

 

Acceptable Values:

0 - 5,000

Enter the number of therapeutic C courses used in the previous week (preferred week: Wednesday-Tuesday) in an inpatient, ED, overflow, or outpatient location such as an urgent care, infusion center, or outpatient clinic. This field has been designated as Bamlanivimab/Etsevimab and is required as of 4/07/2021.

 

See Appendix D for additional therapeutic reporting information.

 
Therapeutics

40c. Therapeutic D Courses on Hand

Column Header:

on_hand_supply_

Therapeutic_D_courses

 

Acceptable Values:

0 - 10,000

Enter the number of therapeutic D courses currently in inventory. This field has been designated as Sotrovimab and is required as of 1/19/2022.

See Appendix D for additional information.

 
Therapeutics

40d. Therapeutic D Courses Administered in Last Week

Column Header:

previous_week_

Therapeutic_D_courses_used

 

Acceptable Values:

0 - 5,000

Enter the number of therapeutic D courses used in the previous calendar week (preferred week Wednesday-Tuesday) in an inpatient, ED, overflow, or outpatient location such as an urgent care, infusion center, or outpatient clinic. This field has been designated as Sotrovimab and is required as of 1/19/2022.

 

See Appendix D for additional therapeutic reporting information.

 
Federally Inactive

39c. Current Inventory on hand (in courses) (Optional)

Column Header:

on_hand_supply_

Therapeutic_B_courses

 

Acceptable Values:

0 - 10,000

Enter the number of therapeutic B courses currently in inventory. This field has been designated as Bamlanivimab and is mandatory as of 1/8/2021.Do NOT count Bamlanivimab vials/courses here that are part of the combination Bamlanivimab / Etesevimab product.

Federally Inactive

39d. Courses used in the last week (Optional)

Column Header:

previous_week_

Therapeutic_B_courses_used

 

Acceptable Values:

0

Enter the number of therapeutic B courses used in the previous calendar week in an inpatient, ED, overflow, or outpatient location, such as an urgent care, infusion center, or outpatient clinic. This field has been designated as Bamlanivimab and is mandatory as of 1/8/2021. Do NOT enter Bamlanivimab vials/courses here that are part of the combination Bamlanivimab / Etesevimab product.